AQST Cost of Revenue

Aquestive Therapeutics Inc · Cost of Revenue

AQST logo

AQST Cost of Revenue

Latest reported$17.83M
AQST Cost of Revenue ($16.38M → $17.83M)
High-resolution chart · PNG

AQST cost of revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aquestive Therapeutics Inc Cost of Revenue — Annual fiscal periods (USD)
Period endingCost of Revenue (USD)
17,154,279
17,872,000
20,831,000
19,386,000
14,989,000
12,964,000
20,361,000
20,988,000
19,820,000
16,378,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.